before, clinical trials on GLP-1 drugs have shown their Advantages as being a secondary prevention Instrument for cardiovascular disease (CVD), this means they could lessen the probability of a heart attack or stroke in https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/